Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thyroid neoplasms | D013964 | EFO_0003841 | — | — | 1 | — | — | — | 1 |
Thyroid diseases | D013959 | — | E00-E07 | — | 1 | — | — | — | 1 |
Drug common name | Tranilast |
INN | tranilast |
Description | Tranilast is an amidobenzoic acid that is anthranilic acid in which one of the anilino hydrogens is replaced by a 3,4-dimethoxycinnamoyl group. It has a role as an anti-asthmatic drug, a nephroprotective agent, an anti-allergic agent, a calcium channel blocker, an antineoplastic agent, an aryl hydrocarbon receptor agonist and a hepatoprotective agent. It is a member of cinnamamides, a dimethoxybenzene, an amidobenzoic acid and a secondary carboxamide. It is functionally related to an anthranilic acid. |
Classification | Small molecule |
Drug class | antiasthmatics/antiallergics (not acting primarily as antihistamines) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC |
PDB | — |
CAS-ID | 53902-12-8 |
RxCUI | — |
ChEMBL ID | CHEMBL415324 |
ChEBI ID | 77572 |
PubChem CID | 5282230 |
DrugBank | — |
UNII ID | HVF50SMY6E (ChemIDplus, GSRS) |